SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

コルチコステロイドAPIの世界市場シェアとランキング、総売上高および需要予測 2025-2031

Corticosteroids API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

コルチコステロイドAPIの世界市場シェアとランキング、総売上高および需要予測 2025-2031

商品番号 : SMB-88452

出版社QYResearch
出版年月2025年10月
ページ数151
図表数155
価格タイプシングルユーザライセンス
価格USD 3,950
種別英文調査報告書

コルチコステロイド API の世界市場は、2024 年に 2 億 4,210 万米ドルに達すると推定され、2025 年から 2031 年の予測期間中に 6.1% の CAGR で成長し、2031 年までに 3 億 6,450 万米ドルに再調整された規模になると予測されています。

コルチコステロイドの有効成分（API）は、抗炎症作用、免疫抑制作用、抗アレルギー作用を持つコルチコステロイド薬の製造に用いられる主要な原料です。これらのAPIには、ヒドロコルチゾン、プレドニゾロン、デキサメタゾン、ベタメタゾンなどの化合物が含まれており、喘息、関節リウマチ、皮膚疾患、自己免疫疾患などの治療に不可欠です。コルチコステロイドAPIの製造には、複雑な化学合成と厳格な品質管理が求められ、高い純度、有効性、そして米国FDA、EU EMA、中国NMPAなどの規制基準への準拠が保証されています。特に皮膚科、呼吸器疾患、臓器移植において、コルチコステロイドベースの治療薬の需要が高まり続けているため、コルチコステロイドAPI市場は製薬業界において依然として重要なセグメントとなっています。

近年、コルチコステロイドAPI市場は、主に製薬業界の需要に牽引され、安定した成長を維持しています。炎症、免疫抑制、皮膚疾患、呼吸器疾患の治療に広く用いられる主要成分であるコルチコステロイドAPIは、世界的に需要が高まっています。人口の高齢化、慢性疾患の有病率上昇、医療制度の改善といった要因が、高品質なAPIの需要増加に寄与しています。さらに、ジェネリック医薬品業界の拡大も市場の成長を牽引しており、特に新興国では、政策支援や現地の製薬企業の能力強化によって需要が高まっています。

本レポートは、コルチコステロイドAPIの世界市場について、総販売量、売上高、価格、主要企業の市場シェアとランキングに焦点を当て、地域・国別、タイプ別、用途別の分析も含め、包括的な分析を提供することを目的としています。

コルチコステロイドAPI市場の規模、推定値、および予測は、2024年を基準年として、販売量（トン）と売上高（百万ドル）の観点から提供され、2020年から2031年までの実績データと予測データが含まれています。定量分析と定性分析の両方を用いて、読者が事業戦略や成長戦略を策定し、市場の競争状況を評価し、現在の市場における自社のポジションを分析し、コルチコステロイドAPIに関する情報に基づいた意思決定を行うのに役立ちます。

Report Overview

The global market for Corticosteroids API was estimated to be worth US$ 2421 million in 2024 and is forecast to a readjusted size of US$ 3645 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.

Corticosteroids Active Pharmaceutical Ingredients (APIs) are key raw materials used in the production of corticosteroid medications, which are widely utilized for their anti-inflammatory, immunosuppressive, and anti-allergic properties. These APIs include compounds such as hydrocortisone, prednisolone, dexamethasone, and betamethasone, which are essential in the treatment of conditions like asthma, rheumatoid arthritis, skin disorders, and autoimmune diseases. The production of corticosteroid APIs involves complex chemical synthesis and stringent quality control to ensure high purity, efficacy, and compliance with regulatory standards such as those set by the US FDA, EU EMA, and China NMPA. As demand for corticosteroid-based treatments continues to grow, particularly in dermatology, respiratory diseases, and organ transplantation, the corticosteroid API market remains a crucial segment within the pharmaceutical industry.

The corticosteroids API market has maintained stable growth in recent years, driven primarily by the pharmaceutical industry’s demand. As a key component widely used in the treatment of inflammation, immunosuppression, dermatological conditions, and respiratory diseases, corticosteroids APIs continue to be in demand globally. Factors such as an aging population, rising prevalence of chronic diseases, and improvements in healthcare systems contribute to the increasing need for high-quality APIs. Additionally, the expansion of the generic drug industry has fueled market growth, particularly in emerging economies where policy support and the enhancement of local pharmaceutical capabilities are strengthening demand.

Looking ahead, the corticosteroids API market is expected to follow several key trends. Firstly, stricter environmental regulations are driving the need for greener and more compliant manufacturing processes, pushing companies to invest in R&D to reduce emissions and improve production efficiency. Secondly, as market competition intensifies, some high-end corticosteroid products will shift toward high-value generics following patent expirations, enabling differentiation strategies. Additionally, supply chain localization is becoming more prominent, with certain countries and regions strengthening their domestic API supply capabilities to reduce import dependency, impacting the global market structure. Furthermore, advancements in biotechnology may introduce new synthetic pathways and alternative therapies that could pose a challenge to the traditional corticosteroids API market.

Key growth drivers include rising medical demand, expansion of the global pharmaceutical industry, and policy support, particularly in emerging markets where governments encourage local production and offer tax incentives. Additionally, advancements in production technology, formulation innovations, and new indications are creating new growth opportunities. However, the industry faces challenges such as fluctuations in raw material prices, rising environmental compliance costs, and intense competition among leading manufacturers. Stricter global regulatory policies impose higher compliance requirements, potentially driving some companies out of the market. Moreover, increasing competition in the generics sector is putting pricing pressure on APIs, affecting overall profitability.

This report aims to provide a comprehensive presentation of the global market for Corticosteroids API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Corticosteroids API by region & country, by Type, and by Application.

The Corticosteroids API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroids API.

Market Segmentation

By Company

  •     Pfizer CentreOne
  •     EUROAPI
  •     GlaxoSmithKline
  •     Teva Pharmaceutical Industries
  •     Hovione
  •     Axplora
  •     Steroid SpA
  •     Avik Pharmaceutical
  •     Anuh Pharma
  •     Symbiotec Pharmalab
  •     Sun Pharmaceutical
  •     Cipla
  •     Wellona Pharma
  •     Tianjin Tianyao Pharmaceuticals
  •     Zhejiang Xianju Pharmaceutical
  •     Guangdong VTR BioTech
  •     Zhejiang Xianju Xianle Pharmaceutical
  •     Tianjin Pacific Pharmaceutical
  •     Shandong Xinhua Pharmaceutica Group
  •     Jiangsu Lianhuan Pharmaceutical
  •     Shanghai New Hualian Pharmaceutical
  •     Shandong Taihua Biotech
  •     Shandong Sito Bio-technology
  •     Zhejiang Xianju Junye Pharmaceutical

Segment by Type

  •     Prednisone Series
  •     Dexamethasone Series
  •     Betamethasone Series
  •     Hydrocortisone Series
  •     Others

Segment by Application

  •     Injectable Drugs
  •     Oral Drugs
  •     Topical Drugs
  •     Inhaled Drugs

By Region

North America

  •         United States
  •         Canada

Asia-Pacific

  •         China
  •         Japan
  •         South Korea
  •         Southeast Asia
  •         India
  •         Australia
  •         Rest of Asia-Pacific

Europe

  •         Germany
  •         France
  •         U.K.
  •         Italy
  •         Netherlands
  •         Nordic Countries
  •         Rest of Europe

Latin America

  •         Mexico
  •         Brazil
  •         Rest of Latin America

Middle East & Africa

  •         Turkey
  •         Saudi Arabia
  •         UAE
  •         Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Corticosteroids API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Corticosteroids API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Corticosteroids API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

1.1 Corticosteroids API Product Introduction

1.2 Global Corticosteroids API Market Size Forecast

1.2.1 Global Corticosteroids API Sales Value (2020-2031)

1.2.2 Global Corticosteroids API Sales Volume (2020-2031)

1.2.3 Global Corticosteroids API Sales Price (2020-2031)

1.3 Corticosteroids API Market Trends & Drivers

1.3.1 Corticosteroids API Industry Trends

1.3.2 Corticosteroids API Market Drivers & Opportunity

1.3.3 Corticosteroids API Market Challenges

1.3.4 Corticosteroids API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Corticosteroids API Players Revenue Ranking (2024)

2.2 Global Corticosteroids API Revenue by Company (2020-2025)

2.3 Global Corticosteroids API Players Sales Volume Ranking (2024)

2.4 Global Corticosteroids API Sales Volume by Company Players (2020-2025)

2.5 Global Corticosteroids API Average Price by Company (2020-2025)

2.6 Key Manufacturers Corticosteroids API Manufacturing Base and Headquarters

2.7 Key Manufacturers Corticosteroids API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Corticosteroids API

2.9 Corticosteroids API Market Competitive Analysis

2.9.1 Corticosteroids API Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Corticosteroids API Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroids API as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Prednisone Series

3.1.2 Dexamethasone Series

3.1.3 Betamethasone Series

3.1.4 Hydrocortisone Series

3.1.5 Others

3.2 Global Corticosteroids API Sales Value by Type

3.2.1 Global Corticosteroids API Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Corticosteroids API Sales Value, by Type (2020-2031)

3.2.3 Global Corticosteroids API Sales Value, by Type (%) (2020-2031)

3.3 Global Corticosteroids API Sales Volume by Type

3.3.1 Global Corticosteroids API Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Corticosteroids API Sales Volume, by Type (2020-2031)

3.3.3 Global Corticosteroids API Sales Volume, by Type (%) (2020-2031)

3.4 Global Corticosteroids API Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Injectable Drugs

4.1.2 Oral Drugs

4.1.3 Topical Drugs

4.1.4 Inhaled Drugs

4.2 Global Corticosteroids API Sales Value by Application

4.2.1 Global Corticosteroids API Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Corticosteroids API Sales Value, by Application (2020-2031)

4.2.3 Global Corticosteroids API Sales Value, by Application (%) (2020-2031)

4.3 Global Corticosteroids API Sales Volume by Application

4.3.1 Global Corticosteroids API Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Corticosteroids API Sales Volume, by Application (2020-2031)

4.3.3 Global Corticosteroids API Sales Volume, by Application (%) (2020-2031)

4.4 Global Corticosteroids API Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Corticosteroids API Sales Value by Region

5.1.1 Global Corticosteroids API Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Corticosteroids API Sales Value by Region (2020-2025)

5.1.3 Global Corticosteroids API Sales Value by Region (2026-2031)

5.1.4 Global Corticosteroids API Sales Value by Region (%), (2020-2031)

5.2 Global Corticosteroids API Sales Volume by Region

5.2.1 Global Corticosteroids API Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Corticosteroids API Sales Volume by Region (2020-2025)

5.2.3 Global Corticosteroids API Sales Volume by Region (2026-2031)

5.2.4 Global Corticosteroids API Sales Volume by Region (%), (2020-2031)

5.3 Global Corticosteroids API Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Corticosteroids API Sales Value, 2020-2031

5.4.2 North America Corticosteroids API Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Corticosteroids API Sales Value, 2020-2031

5.5.2 Europe Corticosteroids API Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Corticosteroids API Sales Value, 2020-2031

5.6.2 Asia Pacific Corticosteroids API Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Corticosteroids API Sales Value, 2020-2031

5.7.2 South America Corticosteroids API Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Corticosteroids API Sales Value, 2020-2031

5.8.2 Middle East & Africa Corticosteroids API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Corticosteroids API Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Corticosteroids API Sales Value and Sales Volume

6.2.1 Key Countries/Regions Corticosteroids API Sales Value, 2020-2031

6.2.2 Key Countries/Regions Corticosteroids API Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Corticosteroids API Sales Value, 2020-2031

6.3.2 United States Corticosteroids API Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Corticosteroids API Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Corticosteroids API Sales Value, 2020-2031

6.4.2 Europe Corticosteroids API Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Corticosteroids API Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Corticosteroids API Sales Value, 2020-2031

6.5.2 China Corticosteroids API Sales Value by Type (%), 2024 VS 2031

6.5.3 China Corticosteroids API Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Corticosteroids API Sales Value, 2020-2031

6.6.2 Japan Corticosteroids API Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Corticosteroids API Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Corticosteroids API Sales Value, 2020-2031

6.7.2 South Korea Corticosteroids API Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Corticosteroids API Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Corticosteroids API Sales Value, 2020-2031

6.8.2 Southeast Asia Corticosteroids API Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Corticosteroids API Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Corticosteroids API Sales Value, 2020-2031

6.9.2 India Corticosteroids API Sales Value by Type (%), 2024 VS 2031

6.9.3 India Corticosteroids API Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Pfizer CentreOne

7.1.1 Pfizer CentreOne Company Information

7.1.2 Pfizer CentreOne Introduction and Business Overview

7.1.3 Pfizer CentreOne Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Pfizer CentreOne Corticosteroids API Product Offerings

7.1.5 Pfizer CentreOne Recent Development

7.2 EUROAPI

7.2.1 EUROAPI Company Information

7.2.2 EUROAPI Introduction and Business Overview

7.2.3 EUROAPI Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 EUROAPI Corticosteroids API Product Offerings

7.2.5 EUROAPI Recent Development

7.3 GlaxoSmithKline

7.3.1 GlaxoSmithKline Company Information

7.3.2 GlaxoSmithKline Introduction and Business Overview

7.3.3 GlaxoSmithKline Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 GlaxoSmithKline Corticosteroids API Product Offerings

7.3.5 GlaxoSmithKline Recent Development

7.4 Teva Pharmaceutical Industries

7.4.1 Teva Pharmaceutical Industries Company Information

7.4.2 Teva Pharmaceutical Industries Introduction and Business Overview

7.4.3 Teva Pharmaceutical Industries Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Teva Pharmaceutical Industries Corticosteroids API Product Offerings

7.4.5 Teva Pharmaceutical Industries Recent Development

7.5 Hovione

7.5.1 Hovione Company Information

7.5.2 Hovione Introduction and Business Overview

7.5.3 Hovione Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Hovione Corticosteroids API Product Offerings

7.5.5 Hovione Recent Development

7.6 Axplora

7.6.1 Axplora Company Information

7.6.2 Axplora Introduction and Business Overview

7.6.3 Axplora Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Axplora Corticosteroids API Product Offerings

7.6.5 Axplora Recent Development

7.7 Steroid SpA

7.7.1 Steroid SpA Company Information

7.7.2 Steroid SpA Introduction and Business Overview

7.7.3 Steroid SpA Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Steroid SpA Corticosteroids API Product Offerings

7.7.5 Steroid SpA Recent Development

7.8 Avik Pharmaceutical

7.8.1 Avik Pharmaceutical Company Information

7.8.2 Avik Pharmaceutical Introduction and Business Overview

7.8.3 Avik Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Avik Pharmaceutical Corticosteroids API Product Offerings

7.8.5 Avik Pharmaceutical Recent Development

7.9 Anuh Pharma

7.9.1 Anuh Pharma Company Information

7.9.2 Anuh Pharma Introduction and Business Overview

7.9.3 Anuh Pharma Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Anuh Pharma Corticosteroids API Product Offerings

7.9.5 Anuh Pharma Recent Development

7.10 Symbiotec Pharmalab

7.10.1 Symbiotec Pharmalab Company Information

7.10.2 Symbiotec Pharmalab Introduction and Business Overview

7.10.3 Symbiotec Pharmalab Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Symbiotec Pharmalab Corticosteroids API Product Offerings

7.10.5 Symbiotec Pharmalab Recent Development

7.11 Sun Pharmaceutical

7.11.1 Sun Pharmaceutical Company Information

7.11.2 Sun Pharmaceutical Introduction and Business Overview

7.11.3 Sun Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Sun Pharmaceutical Corticosteroids API Product Offerings

7.11.5 Sun Pharmaceutical Recent Development

7.12 Cipla

7.12.1 Cipla Company Information

7.12.2 Cipla Introduction and Business Overview

7.12.3 Cipla Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Cipla Corticosteroids API Product Offerings

7.12.5 Cipla Recent Development

7.13 Wellona Pharma

7.13.1 Wellona Pharma Company Information

7.13.2 Wellona Pharma Introduction and Business Overview

7.13.3 Wellona Pharma Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.13.4 Wellona Pharma Corticosteroids API Product Offerings

7.13.5 Wellona Pharma Recent Development

7.14 Tianjin Tianyao Pharmaceuticals

7.14.1 Tianjin Tianyao Pharmaceuticals Company Information

7.14.2 Tianjin Tianyao Pharmaceuticals Introduction and Business Overview

7.14.3 Tianjin Tianyao Pharmaceuticals Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.14.4 Tianjin Tianyao Pharmaceuticals Corticosteroids API Product Offerings

7.14.5 Tianjin Tianyao Pharmaceuticals Recent Development

7.15 Zhejiang Xianju Pharmaceutical

7.15.1 Zhejiang Xianju Pharmaceutical Company Information

7.15.2 Zhejiang Xianju Pharmaceutical Introduction and Business Overview

7.15.3 Zhejiang Xianju Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.15.4 Zhejiang Xianju Pharmaceutical Corticosteroids API Product Offerings

7.15.5 Zhejiang Xianju Pharmaceutical Recent Development

7.16 Guangdong VTR BioTech

7.16.1 Guangdong VTR BioTech Company Information

7.16.2 Guangdong VTR BioTech Introduction and Business Overview

7.16.3 Guangdong VTR BioTech Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.16.4 Guangdong VTR BioTech Corticosteroids API Product Offerings

7.16.5 Guangdong VTR BioTech Recent Development

7.17 Zhejiang Xianju Xianle Pharmaceutical

7.17.1 Zhejiang Xianju Xianle Pharmaceutical Company Information

7.17.2 Zhejiang Xianju Xianle Pharmaceutical Introduction and Business Overview

7.17.3 Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.17.4 Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Product Offerings

7.17.5 Zhejiang Xianju Xianle Pharmaceutical Recent Development

7.18 Tianjin Pacific Pharmaceutical

7.18.1 Tianjin Pacific Pharmaceutical Company Information

7.18.2 Tianjin Pacific Pharmaceutical Introduction and Business Overview

7.18.3 Tianjin Pacific Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.18.4 Tianjin Pacific Pharmaceutical Corticosteroids API Product Offerings

7.18.5 Tianjin Pacific Pharmaceutical Recent Development

7.19 Shandong Xinhua Pharmaceutica Group

7.19.1 Shandong Xinhua Pharmaceutica Group Company Information

7.19.2 Shandong Xinhua Pharmaceutica Group Introduction and Business Overview

7.19.3 Shandong Xinhua Pharmaceutica Group Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.19.4 Shandong Xinhua Pharmaceutica Group Corticosteroids API Product Offerings

7.19.5 Shandong Xinhua Pharmaceutica Group Recent Development

7.20 Jiangsu Lianhuan Pharmaceutical

7.20.1 Jiangsu Lianhuan Pharmaceutical Company Information

7.20.2 Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview

7.20.3 Jiangsu Lianhuan Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.20.4 Jiangsu Lianhuan Pharmaceutical Corticosteroids API Product Offerings

7.20.5 Jiangsu Lianhuan Pharmaceutical Recent Development

7.21 Shanghai New Hualian Pharmaceutical

7.21.1 Shanghai New Hualian Pharmaceutical Company Information

7.21.2 Shanghai New Hualian Pharmaceutical Introduction and Business Overview

7.21.3 Shanghai New Hualian Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.21.4 Shanghai New Hualian Pharmaceutical Corticosteroids API Product Offerings

7.21.5 Shanghai New Hualian Pharmaceutical Recent Development

7.22 Shandong Taihua Biotech

7.22.1 Shandong Taihua Biotech Company Information

7.22.2 Shandong Taihua Biotech Introduction and Business Overview

7.22.3 Shandong Taihua Biotech Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.22.4 Shandong Taihua Biotech Corticosteroids API Product Offerings

7.22.5 Shandong Taihua Biotech Recent Development

7.23 Shandong Sito Bio-technology

7.23.1 Shandong Sito Bio-technology Company Information

7.23.2 Shandong Sito Bio-technology Introduction and Business Overview

7.23.3 Shandong Sito Bio-technology Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.23.4 Shandong Sito Bio-technology Corticosteroids API Product Offerings

7.23.5 Shandong Sito Bio-technology Recent Development

7.24 Zhejiang Xianju Junye Pharmaceutical

7.24.1 Zhejiang Xianju Junye Pharmaceutical Company Information

7.24.2 Zhejiang Xianju Junye Pharmaceutical Introduction and Business Overview

7.24.3 Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)

7.24.4 Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Product Offerings

7.24.5 Zhejiang Xianju Junye Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Corticosteroids API Industrial Chain

8.2 Corticosteroids API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Corticosteroids API Sales Model

8.5.2 Sales Channel

8.5.3 Corticosteroids API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

Tables and Figures

List of Tables

Table 1. Corticosteroids API Market Trends

Table 2. Corticosteroids API Market Drivers & Opportunity

Table 3. Corticosteroids API Market Challenges

Table 4. Corticosteroids API Market Restraints

Table 5. Global Corticosteroids API Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Corticosteroids API Revenue Market Share by Company (2020-2025)

Table 7. Global Corticosteroids API Sales Volume by Company (2020-2025) & (Tons)

Table 8. Global Corticosteroids API Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Corticosteroids API Price by Company (2020-2025) & (US$/kg)

Table 10. Key Manufacturers Corticosteroids API Manufacturing Base and Headquarters

Table 11. Key Manufacturers Corticosteroids API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Corticosteroids API

Table 13. Global Corticosteroids API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroids API as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Corticosteroids API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Corticosteroids API Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Corticosteroids API Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Corticosteroids API Sales Market Share in Value by Type (2020-2025)

Table 20. Global Corticosteroids API Sales Market Share in Value by Type (2026-2031)

Table 21. Global Corticosteroids API Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Corticosteroids API Sales Volume by Type (2020-2025) & (Tons)

Table 23. Global Corticosteroids API Sales Volume by Type (2026-2031) & (Tons)

Table 24. Global Corticosteroids API Sales Volume Market Share by Type (2020-2025)

Table 25. Global Corticosteroids API Sales Volume Market Share by Type (2026-2031)

Table 26. Global Corticosteroids API Price by Type (2020-2025) & (US$/kg)

Table 27. Global Corticosteroids API Price by Type (2026-2031) & (US$/kg)

Table 28. Global Corticosteroids API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Corticosteroids API Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Corticosteroids API Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Corticosteroids API Sales Market Share in Value by Application (2020-2025)

Table 32. Global Corticosteroids API Sales Market Share in Value by Application (2026-2031)

Table 33. Global Corticosteroids API Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)

Table 34. Global Corticosteroids API Sales Volume by Application (2020-2025) & (Tons)

Table 35. Global Corticosteroids API Sales Volume by Application (2026-2031) & (Tons)

Table 36. Global Corticosteroids API Sales Volume Market Share by Application (2020-2025)

Table 37. Global Corticosteroids API Sales Volume Market Share by Application (2026-2031)

Table 38. Global Corticosteroids API Price by Application (2020-2025) & (US$/kg)

Table 39. Global Corticosteroids API Price by Application (2026-2031) & (US$/kg)

Table 40. Global Corticosteroids API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Corticosteroids API Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Corticosteroids API Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Corticosteroids API Sales Value by Region (2020-2025) & (%)

Table 44. Global Corticosteroids API Sales Value by Region (2026-2031) & (%)

Table 45. Global Corticosteroids API Sales Volume by Region (Tons): 2020 VS 2024 VS 2031

Table 46. Global Corticosteroids API Sales Volume by Region (2020-2025) & (Tons)

Table 47. Global Corticosteroids API Sales Volume by Region (2026-2031) & (Tons)

Table 48. Global Corticosteroids API Sales Volume by Region (2020-2025) & (%)

Table 49. Global Corticosteroids API Sales Volume by Region (2026-2031) & (%)

Table 50. Global Corticosteroids API Average Price by Region (2020-2025) & (US$/kg)

Table 51. Global Corticosteroids API Average Price by Region (2026-2031) & (US$/kg)

Table 52. Key Countries/Regions Corticosteroids API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Corticosteroids API Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Corticosteroids API Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Corticosteroids API Sales Volume, (2020-2025) & (Tons)

Table 56. Key Countries/Regions Corticosteroids API Sales Volume, (2026-2031) & (Tons)

Table 57. Pfizer CentreOne Company Information

Table 58. Pfizer CentreOne Introduction and Business Overview

Table 59. Pfizer CentreOne Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 60. Pfizer CentreOne Corticosteroids API Product Offerings

Table 61. Pfizer CentreOne Recent Development

Table 62. EUROAPI Company Information

Table 63. EUROAPI Introduction and Business Overview

Table 64. EUROAPI Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 65. EUROAPI Corticosteroids API Product Offerings

Table 66. EUROAPI Recent Development

Table 67. GlaxoSmithKline Company Information

Table 68. GlaxoSmithKline Introduction and Business Overview

Table 69. GlaxoSmithKline Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 70. GlaxoSmithKline Corticosteroids API Product Offerings

Table 71. GlaxoSmithKline Recent Development

Table 72. Teva Pharmaceutical Industries Company Information

Table 73. Teva Pharmaceutical Industries Introduction and Business Overview

Table 74. Teva Pharmaceutical Industries Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 75. Teva Pharmaceutical Industries Corticosteroids API Product Offerings

Table 76. Teva Pharmaceutical Industries Recent Development

Table 77. Hovione Company Information

Table 78. Hovione Introduction and Business Overview

Table 79. Hovione Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 80. Hovione Corticosteroids API Product Offerings

Table 81. Hovione Recent Development

Table 82. Axplora Company Information

Table 83. Axplora Introduction and Business Overview

Table 84. Axplora Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 85. Axplora Corticosteroids API Product Offerings

Table 86. Axplora Recent Development

Table 87. Steroid SpA Company Information

Table 88. Steroid SpA Introduction and Business Overview

Table 89. Steroid SpA Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 90. Steroid SpA Corticosteroids API Product Offerings

Table 91. Steroid SpA Recent Development

Table 92. Avik Pharmaceutical Company Information

Table 93. Avik Pharmaceutical Introduction and Business Overview

Table 94. Avik Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 95. Avik Pharmaceutical Corticosteroids API Product Offerings

Table 96. Avik Pharmaceutical Recent Development

Table 97. Anuh Pharma Company Information

Table 98. Anuh Pharma Introduction and Business Overview

Table 99. Anuh Pharma Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 100. Anuh Pharma Corticosteroids API Product Offerings

Table 101. Anuh Pharma Recent Development

Table 102. Symbiotec Pharmalab Company Information

Table 103. Symbiotec Pharmalab Introduction and Business Overview

Table 104. Symbiotec Pharmalab Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 105. Symbiotec Pharmalab Corticosteroids API Product Offerings

Table 106. Symbiotec Pharmalab Recent Development

Table 107. Sun Pharmaceutical Company Information

Table 108. Sun Pharmaceutical Introduction and Business Overview

Table 109. Sun Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 110. Sun Pharmaceutical Corticosteroids API Product Offerings

Table 111. Sun Pharmaceutical Recent Development

Table 112. Cipla Company Information

Table 113. Cipla Introduction and Business Overview

Table 114. Cipla Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 115. Cipla Corticosteroids API Product Offerings

Table 116. Cipla Recent Development

Table 117. Wellona Pharma Company Information

Table 118. Wellona Pharma Introduction and Business Overview

Table 119. Wellona Pharma Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 120. Wellona Pharma Corticosteroids API Product Offerings

Table 121. Wellona Pharma Recent Development

Table 122. Tianjin Tianyao Pharmaceuticals Company Information

Table 123. Tianjin Tianyao Pharmaceuticals Introduction and Business Overview

Table 124. Tianjin Tianyao Pharmaceuticals Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 125. Tianjin Tianyao Pharmaceuticals Corticosteroids API Product Offerings

Table 126. Tianjin Tianyao Pharmaceuticals Recent Development

Table 127. Zhejiang Xianju Pharmaceutical Company Information

Table 128. Zhejiang Xianju Pharmaceutical Introduction and Business Overview

Table 129. Zhejiang Xianju Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 130. Zhejiang Xianju Pharmaceutical Corticosteroids API Product Offerings

Table 131. Zhejiang Xianju Pharmaceutical Recent Development

Table 132. Guangdong VTR BioTech Company Information

Table 133. Guangdong VTR BioTech Introduction and Business Overview

Table 134. Guangdong VTR BioTech Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 135. Guangdong VTR BioTech Corticosteroids API Product Offerings

Table 136. Guangdong VTR BioTech Recent Development

Table 137. Zhejiang Xianju Xianle Pharmaceutical Company Information

Table 138. Zhejiang Xianju Xianle Pharmaceutical Introduction and Business Overview

Table 139. Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 140. Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Product Offerings

Table 141. Zhejiang Xianju Xianle Pharmaceutical Recent Development

Table 142. Tianjin Pacific Pharmaceutical Company Information

Table 143. Tianjin Pacific Pharmaceutical Introduction and Business Overview

Table 144. Tianjin Pacific Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 145. Tianjin Pacific Pharmaceutical Corticosteroids API Product Offerings

Table 146. Tianjin Pacific Pharmaceutical Recent Development

Table 147. Shandong Xinhua Pharmaceutica Group Company Information

Table 148. Shandong Xinhua Pharmaceutica Group Introduction and Business Overview

Table 149. Shandong Xinhua Pharmaceutica Group Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 150. Shandong Xinhua Pharmaceutica Group Corticosteroids API Product Offerings

Table 151. Shandong Xinhua Pharmaceutica Group Recent Development

Table 152. Jiangsu Lianhuan Pharmaceutical Company Information

Table 153. Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview

Table 154. Jiangsu Lianhuan Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 155. Jiangsu Lianhuan Pharmaceutical Corticosteroids API Product Offerings

Table 156. Jiangsu Lianhuan Pharmaceutical Recent Development

Table 157. Shanghai New Hualian Pharmaceutical Company Information

Table 158. Shanghai New Hualian Pharmaceutical Introduction and Business Overview

Table 159. Shanghai New Hualian Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 160. Shanghai New Hualian Pharmaceutical Corticosteroids API Product Offerings

Table 161. Shanghai New Hualian Pharmaceutical Recent Development

Table 162. Shandong Taihua Biotech Company Information

Table 163. Shandong Taihua Biotech Introduction and Business Overview

Table 164. Shandong Taihua Biotech Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 165. Shandong Taihua Biotech Corticosteroids API Product Offerings

Table 166. Shandong Taihua Biotech Recent Development

Table 167. Shandong Sito Bio-technology Company Information

Table 168. Shandong Sito Bio-technology Introduction and Business Overview

Table 169. Shandong Sito Bio-technology Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 170. Shandong Sito Bio-technology Corticosteroids API Product Offerings

Table 171. Shandong Sito Bio-technology Recent Development

Table 172. Zhejiang Xianju Junye Pharmaceutical Company Information

Table 173. Zhejiang Xianju Junye Pharmaceutical Introduction and Business Overview

Table 174. Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 175. Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Product Offerings

Table 176. Zhejiang Xianju Junye Pharmaceutical Recent Development

Table 177. Key Raw Materials Lists

Table 178. Raw Materials Key Suppliers Lists

Table 179. Corticosteroids API Downstream Customers

Table 180. Corticosteroids API Distributors List

Table 181. Research Programs/Design for This Report

Table 182. Key Data Information from Secondary Sources

Table 183. Key Data Information from Primary Sources

List of Figures

Figure 1. Corticosteroids API Product Picture

Figure 2. Global Corticosteroids API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Corticosteroids API Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Corticosteroids API Sales Volume (2020-2031) & (Tons)

Figure 5. Global Corticosteroids API Sales Price (2020-2031) & (US$/kg)

Figure 6. Corticosteroids API Report Years Considered

Figure 7. Global Corticosteroids API Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Corticosteroids API Players Sales Volume Ranking (2024) & (Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Corticosteroids API Revenue in 2024

Figure 10. Corticosteroids API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Prednisone Series Picture

Figure 12. Dexamethasone Series Picture

Figure 13. Betamethasone Series Picture

Figure 14. Hydrocortisone Series Picture

Figure 15. Others Picture

Figure 16. Global Corticosteroids API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 17. Global Corticosteroids API Sales Value Market Share by Type, 2024 & 2031

Figure 18. Global Corticosteroids API Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)

Figure 19. Global Corticosteroids API Sales Volume Market Share by Type, 2024 & 2031

Figure 20. Global Corticosteroids API Price by Type (2020-2031) & (US$/kg)

Figure 21. Product Picture of Injectable Drugs

Figure 22. Product Picture of Oral Drugs

Figure 23. Product Picture of Topical Drugs

Figure 24. Product Picture of Inhaled Drugs

Figure 25. Global Corticosteroids API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 26. Global Corticosteroids API Sales Value Market Share by Application, 2024 & 2031

Figure 27. Global Corticosteroids API Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)

Figure 28. Global Corticosteroids API Sales Volume Market Share by Application, 2024 & 2031

Figure 29. Global Corticosteroids API Price by Application (2020-2031) & (US$/kg)

Figure 30. North America Corticosteroids API Sales Value (2020-2031) & (US$ Million)

Figure 31. North America Corticosteroids API Sales Value by Country (%), 2024 VS 2031

Figure 32. Europe Corticosteroids API Sales Value, (2020-2031) & (US$ Million)

Figure 33. Europe Corticosteroids API Sales Value by Country (%), 2024 VS 2031

Figure 34. Asia Pacific Corticosteroids API Sales Value, (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Corticosteroids API Sales Value by Region (%), 2024 VS 2031

Figure 36. South America Corticosteroids API Sales Value, (2020-2031) & (US$ Million)

Figure 37. South America Corticosteroids API Sales Value by Country (%), 2024 VS 2031

Figure 38. Middle East & Africa Corticosteroids API Sales Value, (2020-2031) & (US$ Million)

Figure 39. Middle East & Africa Corticosteroids API Sales Value by Country (%), 2024 VS 2031

Figure 40. Key Countries/Regions Corticosteroids API Sales Value (%), (2020-2031)

Figure 41. Key Countries/Regions Corticosteroids API Sales Volume (%), (2020-2031)

Figure 42. United States Corticosteroids API Sales Value, (2020-2031) & (US$ Million)

Figure 43. United States Corticosteroids API Sales Value by Type (%), 2024 VS 2031

Figure 44. United States Corticosteroids API Sales Value by Application (%), 2024 VS 2031

Figure 45. Europe Corticosteroids API Sales Value, (2020-2031) & (US$ Million)

Figure 46. Europe Corticosteroids API Sales Value by Type (%), 2024 VS 2031

Figure 47. Europe Corticosteroids API Sales Value by Application (%), 2024 VS 2031

Figure 48. China Corticosteroids API Sales Value, (2020-2031) & (US$ Million)

Figure 49. China Corticosteroids API Sales Value by Type (%), 2024 VS 2031

Figure 50. China Corticosteroids API Sales Value by Application (%), 2024 VS 2031

Figure 51. Japan Corticosteroids API Sales Value, (2020-2031) & (US$ Million)

Figure 52. Japan Corticosteroids API Sales Value by Type (%), 2024 VS 2031

Figure 53. Japan Corticosteroids API Sales Value by Application (%), 2024 VS 2031

Figure 54. South Korea Corticosteroids API Sales Value, (2020-2031) & (US$ Million)

Figure 55. South Korea Corticosteroids API Sales Value by Type (%), 2024 VS 2031

Figure 56. South Korea Corticosteroids API Sales Value by Application (%), 2024 VS 2031

Figure 57. Southeast Asia Corticosteroids API Sales Value, (2020-2031) & (US$ Million)

Figure 58. Southeast Asia Corticosteroids API Sales Value by Type (%), 2024 VS 2031

Figure 59. Southeast Asia Corticosteroids API Sales Value by Application (%), 2024 VS 2031

Figure 60. India Corticosteroids API Sales Value, (2020-2031) & (US$ Million)

Figure 61. India Corticosteroids API Sales Value by Type (%), 2024 VS 2031

Figure 62. India Corticosteroids API Sales Value by Application (%), 2024 VS 2031

Figure 63. Corticosteroids API Industrial Chain

Figure 64. Corticosteroids API Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

医療・医薬の最新記事8件